The Delhi court's order has renewed focus on the alleged illegal storage and diversion of regulated codeine-based cough syrups under the NDPS Act. Haberdoedas/Unsplash
Corruption

Delhi Court Orders Charges Against Man in 4,300 Kg Codeine Cough Syrup Case Over Alleged Illegal Storage

Delhi court found a prima facie NDPS case after police seized 36,238 bottles of codeine cough syrup.

Author : Tanya Pokhriyal

Key Points

Delhi court ordered NDPS Act charges against Vipin Chawla over the alleged illegal storage of 4,300 kg of codeine cough syrup.
Delhi Police seized 36,238 bottles of codeine cough syrup from an unlicensed Azadpur premises; records for 12,580 bottles were unavailable, according to the prosecution.
The case has raised concerns over the alleged illegal diversion and unauthorized storage of controlled codeine-based medicines.

A Delhi court has ordered the framing of charges against a man accused of allegedly storing more than 4,300 kg of codeine-based cough syrup at an unlicensed premises, holding that the prosecution has established a prima facie case under the Narcotic Drugs and Psychotropic Substances (NDPS) Act. The case stems from a June 16, 2023, Delhi Police Special Cell raid in Azadpur, where officers seized 36,238 bottles of codeine cough syrup from the premises.

In its July 30 order, Special Judge Jitendra Pratap Singh said the quantity recovered was far above the one-kilogram commercial quantity prescribed for codeine under the NDPS Act and observed that the material on record raised "grave suspicion" about Vipin Chawla's alleged involvement in the illegal procurement, storage, and distribution of the psychotropic substance.

Delhi Court Rejects Defense in 4,300 Kg Codeine Cough Syrup Seizure Case

According to the July 30 court order, Vipin Chawla argued that he was only a manager at M/s Surya Pharma and that the stock was being returned to the supplier following a government ban on certain codeine combinations. He also maintained that the company held valid licenses.

The court rejected the defense, observing that the cough syrup was stored at an unlicensed premises and that Chawla had provided the keys to open the shop during the Delhi Police Special Cell raid.

The prosecution alleged that 48,818 bottles had originally been supplied, but only 36,238 bottles were recovered. The court further noted that sale records for the remaining 12,580 bottles were unavailable, suggesting they may have been "illicitly disposed of in the market."

Forensic Evidence Strengthens Delhi Court's Codeine Cough Syrup Case

The court noted that forensic reports linked Vipin Chawla's signatures to questioned invoices, connecting him to the alleged procurement of the contraband. It also referred to the alleged procurement chain, supplier dealings, call detail record (CDR) connectivity, and the absence of lawful storage records while concluding that sufficient material existed to frame charges.

As reported by Medical Dialogues, the Delhi court observed in its July 30 order, "These circumstances, taken together, prima facie raise grave suspicion regarding involvement of the accused in illegal procurement, storage and distribution of psychotropic substance." The court subsequently held that a prima facie case was made out to frame charges against Chawla under Sections 22(c) and 29 of the NDPS Act.

Codeine-containing cough syrups are regulated medicines in India due to their potential for misuse and diversion into unauthorized supply chains.

Why Codeine-Based Cough Syrup Is Regulated Under India's NDPS Act

Codeine is an opioid used in certain prescription cough syrups to suppress severe cough. Because of its potential for dependence and misuse, its manufacture, storage, distribution, and sale are regulated under India's drug control and narcotics laws.

In India, codeine-containing medicines are regulated under the Drugs and Cosmetics Act, 1940, and the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985, with oversight by the Central Drugs Standard Control Organization (CDSCO) and state drug regulatory authorities. Unauthorized possession, storage, or distribution of regulated narcotic or psychotropic substances may attract prosecution under the NDPS Act, depending on the quantity involved and the circumstances of each case.

Also see: Delhi ₹700 Crore Medical Procurement Scam: ACB Hunts Rajiv Rangila After He Allegedly Flees India

Illegal Diversion of Codeine-Based Medicines Remains a Public Health Concern

The case has drawn attention to the importance of ensuring that prescription medicines containing controlled substances are stored, transported, and distributed only through authorized channels. Investigators have alleged that thousands of bottles supplied to the accused could not be accounted for, an allegation that will be examined during trial.

While ordering the framing of charges, the Delhi court observed, "The recovery is of a quantity far beyond the commercial quantity prescribed under the NDPS Act. This circumstance, by itself, is a strong incriminating factor at the stage of charge," according to the July 30 order reported by Medical Dialogues.

The order relates only to the framing of charges and does not determine guilt. The prosecution will now have to prove its case during trial.

Reference:

1. Government of India. The Drugs and Cosmetics Act, 1940. India Code. Accessed August 5, 2026. https://www.indiacode.nic.in/handle/123456789/15278

(Rh/TP/MSM)

How Nurses Can Grow Into Leadership Roles

The Case for Having an Imperfect Memory: A Psychologist Explains

It’s Not Just Business: Why Emotions Are Central to Workplace Management

Do We Really Need 10,000 Steps a Day?

People With Disabilities Fear Service Cuts as Trump’s DOJ Questions Legal Protections